K Number
K141924
Device Name
HD BLOOD PRESSURE MONITOR
Date Cleared
2014-09-08

(54 days)

Product Code
Regulation Number
870.1130
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
HD 3161 Blood Pressure Monitor is intended to be used to measure the systolic and diastolic blood pressure and pulse rate by using a non-invasive technique in which an inflatable cuff is wrapped on the upper arm. This system should only be used for the testing on people over 18 years of age and over. This device is not intended to be a diagnostic device. Contact your physician if hypertensive values are indicated. The cuff circumference is limited to be 9.44 to 16.9 inches (24cm〜43cm).
Device Description
HD 3161 Blood Pressure Monitor measures both systolic and diastolic blood pressure and heart pulse rate via a standard oscillometric method. The oscillometric method senses the vibrating signal via the closed air pipe system and utilizes a microcomputer to automatically sense the characteristics of the pulse signal. Unlike with the traditional measuring method, based on the Korotkov sound, with the oscillometric method the use of a stethoscope is not required. Through simple calculations, this method provides accurate blood pressure readings: the systolic pressure is defined as the blood pressure when the cuff pressure oscillating amplitude begins to increase, while the diastolic blood pressure is defined as the pressure when the cuff pressure oscillating amplitude stops decreasing.
More Information

Not Found

No
The description details a standard oscillometric blood pressure measurement method using a microcomputer for signal processing, which is a traditional technique and does not indicate the use of AI or ML. There are no mentions of AI, ML, or related terms in the provided text.

No
The device is explicitly stated as "not intended to be a diagnostic device," and its primary function is to measure blood pressure and pulse rate, not to treat or alleviate a medical condition.

No

The "Intended Use / Indications for Use" section explicitly states, "This device is not intended to be a diagnostic device."

No

The device description and performance studies clearly indicate the device is a physical blood pressure monitor utilizing an inflatable cuff and oscillometric method, requiring hardware components and testing beyond software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the device is for measuring blood pressure and pulse rate using a non-invasive technique. It explicitly states, "This device is not intended to be a diagnostic device."
  • Device Description: The description details a non-invasive method (oscillometric) for measuring blood pressure and pulse rate. This is a physical measurement, not an in vitro test.
  • IVD Definition: In Vitro Diagnostics (IVDs) are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. This device does not involve testing any samples taken from the body.

Therefore, the HD 3161 Blood Pressure Monitor is a non-invasive medical device for physiological measurement, not an IVD.

N/A

Intended Use / Indications for Use

HD 3161 Blood Pressure Monitor is intended to be used to measure the systolic and diastolic blood pressure and pulse rate by using a non-invasive technique in which an inflatable cuff is wrapped on the upper arm. This system should only be used for the testing on people over 18 years of age and over.

This device is not intended to be a diagnostic device. Contact your physician if hypertensive values are indicated. The cuff circumference is limited to be 9.44 to 16.9 inches (24cm~43cm).

Product codes

DXN

Device Description

HD 3161 Blood Pressure Monitor measures both systolic and diastolic blood pressure and heart pulse rate via a standard oscillometric method. The oscillometric method senses the vibrating signal via the closed air pipe system and utilizes a microcomputer to automatically sense the characteristics of the pulse signal. Unlike with the traditional measuring method, based on the Korotkov sound, with the oscillometric method the use of a stethoscope is not required. Through simple calculations, this method provides accurate blood pressure readings: the systolic pressure is defined as the blood pressure when the cuff pressure oscillating amplitude begins to increase, while the diastolic blood pressure is defined as the pressure when the cuff pressure oscillating amplitude stops decreasing.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Upper arm

Indicated Patient Age Range

over 18 years of age and over.

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

  1. ELECTRIC SAFETY, EMC and Biocompatibility test reports,
    IEC 60601-1:2005 - PASS
    IEC 60601-1-11:2010 - PASS
    EN 1060-1:2002, EN 1060-3:2005 - PASS
    IEC 60601-1-2: 2007 - PASS
    ISO 10993-5:2009 - PASS
    ISO 10993-10:2010 - PASS
    FCC 47 CFR Part 18, ANSI C63.4: 2009 - PASS

  2. PERFORMANCE & CLINICAL TEST
    IEC 80601-2-30:2013
    AAMI / ANSI / ISO 81060-2:2013

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Pressure: ±3mmHg or ±2% of readout value
Pulse: ±4% of reading value

Predicate Device(s)

K100658

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1130 Noninvasive blood pressure measurement system.

(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).

0

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

DEPARTMENT OF HEALTH & HUMAN SERVICES - USA

September 8, 2014

BioCare Asia Corporation Ltd. c/o Dr. Ke-Min Jen Official Correspondent No. 260, Mayun Road New District Suzhou. Jiangsu. 215129 P.R.C.

Re: K141924

Trade/Device Name: HD Blood Pressure Monitor, Upper Arm Type: 3161 Regulation Number: 21 CFR 870.1130 Regulation Name: Non-invasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: July 5, 2014 Received: July 16, 2014

Dear Dr. Ke-Min Jen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply

1

with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours

Arthell Stein

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

K141924

Page 1 of 1

510(k) Number (if known): K141924

Device Name: __ HD Blood Pressure Monitor, Upper Arm Type: 3161

Indications For Use: HD 3161 Blood Pressure Monitor is intended to be used to measure the systolic and diastolic blood pressure and pulse rate by using a non-invasive technique in which an inflatable cuff is wrapped on the upper arm. This system should only be used for the testing on people over 18 years of age and over.

This device is not intended to be a diagnostic device. Contact your physician if hypertensive values are indicated. The cuff circumference is limited to be 9.44 to 16.9 inches (24cm〜43cm).

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Over-The-Counter Use X

3

K141924 Page 1 of 4

Summary of Safety and Effectiveness

(According to 21 CFR 807.92)

510(k) Summary for K141924_

Submitter's information
Name:BioCare Asia Corporation Ltd.
Address:No.260, Mayun Road, New District, Suzhou, Jiangsu, 215129, P.R.C
Phone number:+86 (512) 6809-1772
Fax number:+86 (512) 6809-7761
Representative person:Albert Chen / Administrator
FDA Registration:# 3003979308
510k Contact person:Dr. Jen, Ke-Min
Tel: +886-3-5208829 Fax:+886-3-5209783
Email: ceirs.jen@msa.hinet.net
Date of preparation:July 1, 2014
Device name
Trade name:BioCare Asia HD 3161 Blood Pressure Monitor
Device name:HD Blood Pressure Monitor, Upper Arm Type: 3161
Common name:Blood Pressure Monitor
Classification
Classification name:Non-Invasive Blood Pressure Monitoring System
Regulation number:21CFR Section 870.1130
Class:II (Two) performance standards
Specialty:Cardiovascular
Product code:DXN

4

Predicate devices

U-RIGHT TD-3127 Blood Pressure Monitoring System (K100658) TaiDoc Technology Corporation

Device Information

  • Device description: HD 3161 Blood Pressure Monitor measures both systolic and diastolic blood pressure and heart pulse rate via a standard oscillometric method. The oscillometric method senses the vibrating signal via the closed air pipe system and utilizes a microcomputer to automatically sense the characteristics of the pulse signal. Unlike with the traditional measuring method, based on the Korotkov sound, with the oscillometric method the use of a stethoscope is not required. Through simple calculations, this method provides accurate blood pressure readings: the systolic pressure is defined as the blood pressure when the cuff pressure oscillating amplitude begins to increase, while the diastolic blood pressure is defined as the pressure when the cuff pressure oscillating amplitude stops decreasing.
    Indication for use: HD 3161 Blood Pressure Monitor is intended to be used to measure the systolic and diastolic blood pressure and pulse rate by using a non-invasive technique in which an inflatable cuff is wrapped on the upper arm. This system should only be used for the testing on people over 18 years of age and over.

This device is not intended to be a diagnostic device. Contact your physician if hypertensive values are indicated. The cuff circumference is limited to be 9.44 to 16.9 inches (24cm~43cm).

Test Summary:

    1. ELECTRIC SAFETY, EMC and Biocompatibility test reports,
General safetyIEC 60601-1:2005PASS
IEC 60601-1-11:2010PASS
EN 1060-1:2002, EN 1060-3:2005PASS
EMC conformityIEC 60601-1-2: 2007PASS
BiocompatibilityISO 10993-5:2009PASS
ISO 10993-10:2010PASS
FCC 47 CFR Part 18ANSI C63.4: 2009PASS

5

K141924

Page 3 of 4

2. PERFORMANCE & CLINICAL TEST

IEC 80601-2-30:2013

AAMI / ANSI / ISO 81060-2:2013

Comparison with predicate device and conclusion

Similarities:

Comparison itemProposed devicePredicate device
ApplicantBioCare Asia Corporation Ltd.TaiDoc Technology Corporation
Trade nameBioCare Asia HD 3161 Blood Pressure
MonitorU-RIGHT TD-3127 Blood Pressure
Monitoring System
Model nameHD 3161TD-3127
510K numberNew listingK100658
Technological
characteristicsOscillometric methodOscillometric method
Measuring methodOscillometric method, automatic
inflation and measurementOscillometric method, automatic
inflation and measurement
SensorSemiconductor gauge sensorSemiconductor gauge sensor
Rapid air releaseBy an active electronic control valveBy an active electronic control valve
System
anatomical sitesUpper armUpper arm
Display and user
interactionLCD monitorLCD monitor
Power sourceBatteries or AC adapterBatteries or AC adapter
Measurement rangeSystolic 50 - 250 mmHg
Diastolic 30 - 180 mmHg
Pulse 40 – 199 beats per minuteSystolic 50 - 250 mmHg
Diastolic 30 - 180 mmHg
Pulse 40 - 199 beats per minute
Pressure accuracyPressure: ±3mmHg or ±2% of readout
valuePressure: ±3mmHg or ±2% of readout
value
Pulse accuracy±4% of reading value±4% of reading value
Operating temperature
and humidityTemperature: 32104°F (040°C)
RH:15% to 90%Temperature: 32104°F (040°C)
RH:15% to 90%
Storage temperature
and humidityTemperature: 23122°F (-550°C)
RH:15% to 95%Temperature: 23122°F (-550°C)
RH:15% to 95%
Cuff materialCuff: nylon (PVC bladder, non-latex)
Biocompatibility:
ISO 10993-5:2009, ISO 10993-10:2010Cuff: nylon (PVC bladder, non-latex)
Biocompatibility:
ISO 10993-5:2009, ISO 10993-10:2010

6

K141924

Page 4 of 4

Differences:

Comparison itemProposed devicePredicate device
Dimensions
(LWH) mm134.8(L)x94.6(W)x31.5(H) mm150(L) × 96(W) × 66(H)mm
Weight425g (w batteries)250g
Memory2 * 90 measurements100 measurements
Auto shutoff90 sec after last key operation180 sec after last key operation

Summary with predicate device and conclusion

The new device, HD 3161 Blood Pressure Monitor is substantially equivalent to the U-RIGHT TD-3127 Blood Pressure Monitoring System (K100658) and they are the same upper arm type of the blood pressure monitor.

The intended use and the indications for use of the HD 3161 Blood Pressure Monitor as described in its labeling are the same as the predicate device and the two devices are intended to be used in the same measurement range; in addition, there are the same operating and storage environments.

The HD 3161 Blood Pressure Monitor and the predicate devices are substantially equivalent in all of the technological characteristics of patient contact materials, performance, biocompatibility function, mechanical safety, standards met, electrical safety, and EMC.

The main differences for the two devices are overall dimensions, including dimensions, weight, memory, and the time of auto shutoff. The overall appearance differences are not safety aspect. Thus the new device is substantially equivalent to the predicate devices in this aspect.

BioCare Asia Corporation Ltd. believes this information and the referred documentation to be sufficient for the FDA to find our proposed device substantially equivalent to the predicate product and other products currently in distribution.